Podcasts about Netter

Join the Behind the Knife Surgical Oncology Team as we discuss the two key studies investigating optimal management strategies of neuroendocrine tumors of the small bowel. Hosts: - Timothy Vreeland, MD, FACS (@vreelant) is an Assistant Professor of Surgery at the Uniformed Services University of the Health Sciences and Surgical Oncologist at Brooke Army Medical Center - Daniel Nelson, DO, FACS (@usarmydoc24) is Surgical Oncologist/HPB surgeon at Kaiser LAMC in Los Angeles. - Connor Chick, MD (@connor_chick) is a 2nd Year Surgical Oncology fellow at Ohio State University. - Lexy (Alexandra) Adams, MD, MPH (@lexyadams16) is a 1st Year Surgical Oncology fellow at MD Anderson. - Beth (Elizabeth) Barbera, MD (@elizcarpenter16) is a PGY-6 General Surgery resident at Brooke Army Medical Center Learning Objectives: In this episode we review two important papers that discuss optimal management strategies of neuroendocrine tumors (NET) of the small bowel.  The first paper by Singh and colleagues discusses the NETTER-2 trial investigating the role of radioligand therapy for NET as a first-line treatment.  The second article by Maxwell et all challenges surgical dogma regarding optimal debulking cutoffs for debulking of NET. Links to Papers Referenced in this Episode: 1.     Singh S, Halperin D, Myrehaug S, Herrmann K, Pavel M, Kunz PL, Chasen B, Tafuto S, Lastoria S, Capdevila J, García-Burillo A, Oh DY, Yoo C, Halfdanarson TR, Falk S, Folitar I, Zhang Y, Aimone P, de Herder WW, Ferone D; all the NETTER-2 Trial Investigators. [177Lu]Lu-DOTA-TATE plus long-acting octreotide versus high‑dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2-3, well-differentiated, gastroenteropancreatic neuroendocrine tumours (NETTER-2): an open-label, randomised, phase 3 study. Lancet. 2024 Jun 29;403(10446):2807-2817. doi: 10.1016/S0140-6736(24)00701-3. Epub 2024 Jun 5. PMID: 38851203. https://pubmed.ncbi.nlm.nih.gov/38851203/ 2.     Maxwell JE, Sherman SK, O'Dorisio TM, Bellizzi AM, Howe JR. Liver-directed surgery of neuroendocrine metastases: What is the optimal strategy? Surgery. 2016 Jan;159(1):320-33. doi: 10.1016/j.surg.2015.05.040. Epub 2015 Oct 9. PMID: 26454679; PMCID: PMC4688152. https://pubmed.ncbi.nlm.nih.gov/26454679/ Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.   If you liked this episode, check out our recent episodes here: https://app.behindtheknife.org/listen

In this edition, FRANCE 24's Charles Pellegrin speaks with Benjamin Netter, the co-founder of Riot. The French company provides real-time cybersecurity for over 1.5 million employees around the world and has raised $45 million since it was launched in 2020. Netter provides insights on the French tech ecosystem, the magnitude of cybersecurity threats in the age of artificial intelligence, and how AI can also be used to increase protection.

This episode is different because Benjamin Netter gets it. This dude went from fashion to fintech to cybersecurity. Not because he planned it that way. Because he saw problems that needed solving. Benjamin founded Riot after running a fintech company handling hundreds of millions of euros. While he was spending massive money protecting complex systems, one employee clicked the wrong email. Changed everything. That's when he realized hackers aren't trying to crack some sophisticated code. They're going after Bob. You know Bob. Every company has a Bob who clicks on everything. So Benjamin started waking up two hours early. Building what would become Riot. Testing it on his own team first. The CFO was the first to fall for it. That was his wake-up call. The guy raised $12 million in Series A funding. Not by pitching some dream. By showing revenue. Showing results. Proving the concept works. That's how real business gets done. This episode is for every entrepreneur who thinks they need to reinvent everything. Sometimes the biggest opportunity is just making existing solutions actually work for people. Benjamin did that. Made cybersecurity human.Connect:Connect with Rick: https://linktr.ee/mrrickjordanConnect with Benjamin: https://www.tryriot.com/aboutSubscribe & Review to ALL IN with Rick Jordan on YouTube: https://www.youtube.com/c/RickJordanALLINAbout Benjamin : Benjamin is the Founder and CEO of Riot, a cybersecurity platform created for employee protection. Benjamin is an expert at getting inside the minds of hackers and through Riot, he protects employees against cyber attacks through mock phishing drills and cyber awareness programs custom to each user. Benjamin would love to discuss his passion for cybersecurity and helping employees and his own personal entrepreneurial journey.

La Dra. Teresa Alonso, oncóloga médica en el Hospital Universitario Ramón y Cajal en Madrid, España, presentó recientemente en Barranquilla, Colombia, durante el congreso de CLOC, los avances más destacados en el tratamiento de los tumores neuroendocrinos (TNE) durante el 2024. La experta abordó dos ensayos clínicos clave: el estudio NETTER-2, que evaluó el uso de radioligandos con lutecio-177 dotatate en pacientes con TNE pancreáticos avanzados, y el estudio CABINET, que probó cabozantinib en pacientes con TNE pancreáticos y extraparenquimatosos, incluidos TNE pulmonares. Ambos estudios mostraron un claro beneficio en términos de supervivencia libre de progresión, consolidándose como nuevas opciones terapéuticas en el manejo de estos tumores. Cobertura apoyada por el Curso Latinoamericano de Oncología Clínica (CLOC). Fecha de grabación: 08 de marzo de 2025     Todos los comentarios emitidos por los participantes son a título personal y no reflejan la opinión de ScienceLink u otros. Se deberá revisar las indicaciones aprobadas en el país para cada uno de los tratamientos y medicamentos comentados. Las opiniones vertidas en este programa son responsabilidad de los participantes o entrevistados, ScienceLink las ha incluido con fines educativos. Este material está dirigido a profesionales de la salud exclusivamente. 

Carolyn McMakin, MA, DC - frequencyspecific.com/about Kim Pittis, LCSP, (PHYS), MT - fsmsports365.com 00:13 Patient Case: Lumbar Spine Surgery and Nerve Pain 02:05 Treatment Protocols and Techniques 02:39 Case Study: Diabetic Neuropathy Misdiagnosis 05:36 Collaborative Diagnosis and Treatment 11:57 Exploring Anatomy with Netter 19:42 Understanding AB Pairs in Treatment 31:38 Managing Diabetes in the Elderly 32:29 Understanding Diabetic Neuropathy 36:20 Physical Exams and Patient Interaction 40:50 Diagnosing and Treating Pain 45:17 Complex Pain Cases and CRPS 51:25 SI Joint Dysfunction and Treatment **Understanding Patient Histories and Symptoms** A comprehensive understanding of patient histories and symptoms is crucial for effective treatment planning. For instance, distinguishing between different types of nerve pain, such as diabetic neuropathies and radiculopathies, requires a meticulous examination and thoughtful questioning. Symptoms often present differently, depending on underlying issues. Diabetic neuropathy typically presents as symmetrical numbness following a "socks and gloves" pattern, while radiculopathy follows a dermatomal pattern and is often aggravated by movement. Understanding these distinctions can direct practitioners towards more accurate diagnostic and treatment pathways. **Utilizing FSM in Clinical Practice** FSM provides unique opportunities to address conditions that are otherwise difficult to treat. For example, when dealing with chronic pain or nerve severance, FSM can be tailored to target specific pathologies and tissues, promoting healing and managing pain. Practicing an evidence-based thought process is essential, as it allows the clinician to customize FSM protocols to suit individual patient needs. When treating acute injuries, practitioners are advised to focus on reducing inflammation without disrupting the natural healing process. For instance, in the management of acute sprains or strains, practitioners may opt to stimulate circulation through the fascia instead of lymphatic tissues directly with FSM, potentially providing notable relief and improved functional outcomes. **Collaboration for Better Diagnosis** Diagnosis often benefits from a collaborative approach. Utilizing anatomical references, such as Netter's Architecture, during patient consultations can enhance understanding and engagement, enabling patients to visualize and comprehend the therapeutic focus. This collaboration not only assists in accurate diagnosis but also empowers patients by involving them actively in their treatment plans. **Managing Complex Cases** For intricate cases, such as those involving chronic low back pain or neuropathic issues following surgical interventions, FSM offers a pathway to alleviate symptoms through targeted protocols. It is essential for practitioners to closely consider the full scope of the patient's history, assess the interplay of symptoms, and explore multifaceted treatment angles. This might include addressing both physical and neurological aspects of pain, using FSM's ability to treat tissue-specific pathologies. **Continual Education and Adaptation** Staying informed about the latest research and developments in FSM is crucial. Medical practitioners are encouraged to engage with ongoing educational resources and remain adaptable in their practice. This ensures that treatment protocols are aligned with the latest evidence, maximizing therapy effectiveness for complex pain and healing challenges. Integrating Frequency Specific Microcurrent into clinical practice offers a novel, holistic approach to managing complex pain and rehabilitation scenarios. By fostering a deep understanding of patient symptoms, collaborating for accurate diagnosis, and continually adapting treatment protocols, practitioners can enhance their therapeutic impact, leading to improved patient outcomes and satisfaction.

Ende Oktober 2024 erschoss ein Oberösterreicher zwei seiner Jagdfeinde, und danach sich selbst. Die Psyche des „Rächers vom Mühlviertel“ – der vermutlich noch viel mehr Menschen ermorden wollte.

Pour l'épisode #303 je recevais Emmanuel Straschnov. On en débrief avec Benjamin.**Recrutez les meilleurs développeurs grâce à Indeed !** "Trouver des développeurs compétents et passionnés, comme les auditeurs d'If This Then Dev, peut être un vrai défi. Avec Indeed, connectez-vous rapidement avec des candidats qualifiés qui sauront s'épanouir dans votre entreprise. Profitez dès maintenant d'un crédit de 100 euros pour sponsoriser votre offre d'emploi : go.indeed.com/IFTTD."🎙️ Soutenez le podcast If This Then Dev ! 🎙️ Chaque contribution aide à maintenir et améliorer nos épisodes. Cliquez ici pour nous soutenir sur Tipeee 🙏Archives | Site | Boutique | TikTok | Discord | Twitter | LinkedIn | Instagram | Youtube | Twitch | Job Board |

In dieser Episode des Ja klaHR! Podcasts spricht Stefan, DER HR-Architekt, mit Vanessa Reynolds – Wirtschaftspsychologin, Gründerin von Candidized und Expertin für psychologisch fundiertes Recruiting und moderne Eignungsdiagnostik.

In dieser Folge zu unserer Serie Gegen das Vergessen spricht Petra Lynen mit Irmtraut Koop über die beeindruckende Lebensgeschichte von Ernst Oppenheimer, Mitglied der DGVS und Verfolgter der NS-Zeit. Wir beleuchten seinen Weg von einer vielversprechenden Karriere bei Boehringer Ingelheim über seine Flucht in die USA, seiner Mitwirkung am Netter-Atlas bis hin zu seiner späten Anerkennung in der Fachwelt. Ernst Oppenheimer reiht sich ein in die Reihe derjenigen, die den durch die NS-Diktatur getriebenen Wissensverlust deutlich machen. Hören Sie rein und begleiten Sie uns auf dieser inspirierenden Reise durch Geschichte und Wissenschaft!

"Sur tout le reste on est en retard, mais sur la tech on est à la pointe" Le D.E.V. de la semaine est Benjamin Netter, fondateur de Riot. Ayant commencé sa carrière en tant que développeur à l'âge de dix ans, Benjamin est passé du rôle de CTO à celui de CEO. Il a lancé Riot, une plateforme de protection des employés face aux cyberattaques. Dans le podcast, Benjamin expose les défis de la transition vers un rôle de CEO, y compris l'importance de penser à un niveau plus stratégique, comme le marketing. Il souligne également la nécessité de recruter des experts divers pour réussir et parle des menaces émergentes en matière de cybersécurité, comme l'IA. Benjamin imagine un futur avec une sécurité renforcée au sein des entreprises pour faire face à l'évolution constante des menaces numériques.Chapitrages00:00:53 : Création d'une Start-up00:01:16 : Présentation de Benjamin00:04:32 : De CTO à CEO00:05:40 : Transition vers la cybersécurité00:08:27 : Évolution du rôle de CEO00:10:32 : Recrutement et expertise00:16:06 : Définition d'une entreprise tech00:18:06 : Vision et stratégie de produit00:22:06 : Développement de la technologie00:36:35 : Futur de Riot00:44:25 : Éducation à la cybersécurité00:50:21 : Confiance et données personnelles00:52:08 : Lecture recommandée00:52:32 : Conclusion et recommandations Liens évoqués pendant l'émission Magellan de Stefan Zweig **Recrutez les meilleurs développeurs grâce à Indeed !** "Trouver des développeurs compétents et passionnés, comme les auditeurs d'If This Then Dev, peut être un vrai défi. Avec Indeed, connectez-vous rapidement avec des candidats qualifiés qui sauront s'épanouir dans votre entreprise. Profitez dès maintenant d'un crédit de 100 euros pour sponsoriser votre offre d'emploi : go.indeed.com/IFTTD."🎙️ Soutenez le podcast If This Then Dev ! 🎙️ Chaque contribution aide à maintenir et améliorer nos épisodes. Cliquez ici pour nous soutenir sur Tipeee 🙏Archives | Site | Boutique | TikTok | Discord | Twitter | LinkedIn | Instagram | Youtube | Twitch | Job Board |

Join the Behind the Knife Surgical Oncology Team as we discuss the presentation, work-up, and management of neuroendocrine tumors of the small bowel. Learning Objectives: In this episode, we review the basics of neuroendocrine (NE) tumors of the small bowel, including how to evaluate patients with presenting symptoms consistent with NE tumors, initial work-up, staging, and management.  We discuss key concepts including DOTATATE scans and medical therapies high yield for direct patient care and board exams.  Hosts: Timothy Vreeland, MD, FACS (@vreelant) is an Assistant Professor of Surgery at the Uniformed Services University of the Health Sciences and Surgical Oncologist at Brooke Army Medical Center Daniel Nelson, DO, FACS (@usarmydoc24) is Surgical Oncologist/HPB surgeon at Kaiser LAMC in Los Angeles. Connor Chick, MD (@connor_chick) is a 2nd Year Surgical Oncology fellow at Ohio State University. Lexy (Alexandra) Adams, MD, MPH (@lexyadams16) is a 1st Year Surgical Oncology fellow at MD Anderson. Beth (Elizabeth) Barbera, MD (@elizcarpenter16) is a PGY-6 General Surgery resident at Brooke Army Medical Center Links to Paper Referenced in this Episode: Strosberg J, El-Haddad G, Wolin E, Hendifar A, Yao J, Chasen B, Mittra E, Kunz PL, Kulke MH, Jacene H, Bushnell D, O'Dorisio TM, Baum RP, Kulkarni HR, Caplin M, Lebtahi R, Hobday T, Delpassand E, Van Cutsem E, Benson A, Srirajaskanthan R, Pavel M, Mora J, Berlin J, Grande E, Reed N, Seregni E, Öberg K, Lopera Sierra M, Santoro P, Thevenet T, Erion JL, Ruszniewski P, Kwekkeboom D, Krenning E; NETTER-1 Trial Investigators. Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors. N Engl J Med. 2017 Jan 12;376(2):125-135. doi: 10.1056/NEJMoa1607427. PMID: 28076709; PMCID: PMC5895095. https://pubmed.ncbi.nlm.nih.gov/28076709/ ***SPECIALTY TEAM APPLICATION LINK: https://docs.google.com/forms/d/e/1FAIpQLSdX2a_zsiyaz-NwxKuUUa5cUFolWhOw3945ZRFoRcJR1wjZ4w/viewform?usp=sharing Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.

Cette semaine, tu vas découvrir Riot, un belle startup basée à Paris et son fondateur Benjamin est ton invité

Coacher les employés face à l'explosion des cyberattaques, telle est la mission de Riot qui lève 30M$ cette semaine pour accélérer en 2025

Kim Pittis, LCSP, (PHYS), MT - fsmsports365.com Carolyn McMakin, MA, DC - frequencyspecific.com/getstarted 00:14 A Surprising Medical Case 03:08 Exploring Cranial Nerve Frequencies 04:31 Understanding Muscle Spasticity 06:40 Neurological Insights and Patient Education 09:19 FSM Practitioners and Complex Cases 14:10 Muscle Mechanics and Treatment Strategies 25:39 TMJ and Retrodiscal Tissue Treatment 29:13 Exploring TMJ and Facial Nerve Innervation 30:42 Understanding Trigeminal and Facial Nerve Functions 31:55 Upcoming Events and Notable Speakers 33:18 Heart Health and FSM Applications 43:38 Addressing Stenosis and FSM Treatment 52:19 Concluding Remarks and Next Steps Understanding Complex Neurological Cases The podcast opens with a fascinating case study involving a Ph.D. research biochemist who developed a condition known as Cavernous Hemangioma. This case illustrates the intricacies of treating fragile neurological conditions with FSM. The discussion delves into the importance of understanding cranial nerves and their frequencies, highlighting the necessity of increased secretions in nerves and innovative approaches to manage cranial nerve involvement. Practitioners are encouraged to familiarize themselves with the specifics of cranial nerve treatment, particularly how conditions such as thalamic pain can be influenced by surgery-related changes. Handling Muscle Spasticity and Weakness The session further delves into muscle management, emphasizing the concept of "tight weakness" and "stretch weakness" in muscle physiology. For medical practitioners, understanding the cellular mechanics, including the role of actin and myosin, can be crucial in diagnosing and managing spastic or chronically shortened muscles. The podcast underscores the benefit of FSM in increasing ATP for muscle relaxation and strengthening—both critical for optimal muscle function. Stenosis: Misconceptions and Treatment Strategies Stenosis, a common concern, is addressed with clarity, dismissing the myth that FSM is contraindicated for such conditions. Practitioners learn that understanding the mechanics of spinal fluid flow and managing inflammation are key to effective treatment. Special attention is given to cervical and lumbar stenosis, advising on how to approach these differently based on anatomical and physiological variances. Innovative Techniques for Treating Shoulder and TMJ Issues The podcast emphasizes the versatility of FSM in treating complex conditions like shoulder injuries and TMJ disorders. It introduces the idea of using specific frequencies for labrum and annular ligament issues, which can be potent in resolving chronic pain and dysfunction in shoulder and TMJ patients. Genetic and Mitochondrial Considerations in Treatment The session discusses a genetic condition, SPG7, shedding light on the importance of understanding genetic and mitochondrial contributions to disease progression. For practitioners, using FSM for abnormal protein accumulation and mitochondrial health can stave off advancement in otherwise degenerative conditions. Final Thoughts and Peer Involvement The concluding parts stress the importance of continuous learning and collaboration in the FSM community, urging practitioners to remain curious and collaborative, utilizing tools like Netter's Anatomy for inspiration. Sharing case studies and engaging in forums can enhance understanding and therapeutic outcomes in practice. By internalizing the teachings and discussions from this detailed podcast, medical practitioners can unlock new avenues for healing and patient care, integrating FSM into their standard practices for improved outcomes. As always, engagement with the FSM community for continued learning and sharing of knowledge is encouraged, helping to expand the collective understanding and effectiveness of FSM.  

Dans cet épisode, Julien Netter, maitre de conférences en science de l’éducation à l’université Paris Est Créteil, propose de réfléchir à quelques points de vigilance lorsqu’on se lance dans un dispositif d’éducation artistique et culturelle.

Dans cet épisode, Julien Netter, maitre de conférence en sciences de l’éducation à l’université Paris Est Créteil, nous propose une immersion dans une visite d’élèves au musée en se demandant au final, qu’apprennent-ils ?  

CancerNetwork® spoke with Natasha Bahri, MD, MS, and Daneng Li, MD, about their Hot Topics article titled Casting a Wide NET: When Is the Optimal Time for 177Lu-Dotatate Treatment?, which was published in the November 2024 issue of ONCOLOGY®. Their article focused on findings related to the use of 177Lutetium-Dotatate (177Lu-dotatate; Lutathera) in patients with neuroendocrine tumors (NETs) and whether these data supported the use of the novel radioligand therapy for this population. Bahri is a PGY-5 chief fellow in Medical Oncology and Hematology at City of Hope National Medical Center in Duarte, California. Li is an associate professor in the Department of Medical Oncology & Therapeutics Research at City of Hope Comprehensive Cancer Center in Duarte, California, and a gastrointestinal editorial board member of ONCOLOGY. Bahri and Li discussed findings from the phase 3 NETTER-1 trial (NCT01578239) assessing 177Lu-dotatate for those with inoperable, locally advanced or metastatic, grade 1/2 midgut NETs following progression on long-acting repeatable octreotide therapy. Although these findings established a significant efficacy signal with the radioligand therapy, Li noted that questions remained regarding the sequencing of 177Lu-dotatate alongside other therapies in the treatment landscape. The conversation also covered efficacy, safety, and quality-of-life (QOL) data from the phase 3 NETTER-2 trial (NCT03972488), in which investigators assessed high-dose octreotide with or without 177Lu-dotatate among patients with locally advanced or metastatic, well-differentiated, somatostatin receptor–positive gastroenteropancreatic NETs. Although data showed improvements in efficacy with the 177Lu-dotatate combination, there did not appear to be significant differences regarding QOL outcomes between arms. “We're waiting for further long-term follow-up information as there was no difference in the QOL metrics. It's important to think about how these patients' goals align with the therapy that we're giving, and if we're not seeing a difference in the quality of life quite yet, [we need to] look at individual patients, see what their goals are, and match them up to the therapy that we're giving them,” Bahri stated. Although the NETTER-1 and NETTER-2 trials demonstrate “great” results associated with efficacy end points such as progression-free survival, the authors noted that it is crucial to weigh these benefits with the potential toxicities when determining suitable candidates for treatment with 177Lu-dotatate. “There's a lot of nuances in terms of who is the ideal patient that's going to maximally benefit [while] minimizing any risk of serious toxicity in those patients. As a result of that, we're helping to improve their outcomes to the highest bars possible, whether it's quality of life or survival,” Li concluded. References 1.        Strosberg J, El-Haddad G, Wolin E, et al; NETTER-1 Trial Investigators. Phase 3 trial of 177Lu-Dotatate for midgut neuroendocrine tumors. N Engl J Med. 2017;376(2):125-135. doi:10.1056/NEJMoa1607427 2.        Singh S, Halperin D, Myrehaug S, et al; NETTER-2 Trial Investigators. [177Lu]Lu-DOTA-TATE plus long-acting octreotide versus high-dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2-3, well-differentiated, gastroenteropancreatic neuroendocrine tumours (NETTER-2): an open-label, randomised, phase 3 study. Lancet. 2024;403(10446):2807-2817. doi:10.1016/S0140-6736(24)00701-3

Heute am letzten Adventssonntag wird´s Zeit für einen Mann, nachdem zwei Frauen die Wochen vorher waren. Jan ist ein guter Freund geworden, weil ich in Kiel mein Solo gespielt habe und er alle nötigte, Karten zu kaufen. Seitdem lässt er mich täglich lächeln, weil er eine nette kurze lustige Nachricht, ein Bild, einen Text schickt. Oftmals nicht nur lächeln, sondern lauthals lachen, der mir im September Geschenke zum Geburtstag im November schickt mit dem Satz: Aber noch nicht aufmachen... Hört selber, was für ein Netter der Jan ist!

In this episode of SurgOnc Today, Dr. Julie Hallet and Dr. Patricio Polanco, Chair and Vice-Chair of the HPB disease site, are joined by Drs. Ryan Ellis from Indiana University Scholl of Medicine and Allison Martin from Duke University. They will wrap the 2024 HPB year with us by reviewing the top HPB surgical oncology published this year. References/Resources: #5 NETTER-2 #4 NEOLUPANET #3 TRANSMET #2 PANDORINA #1 NORPACT

✨In dieser Folge✨ Lou und ich tauschen uns über den Film aus und vergleichen unsere Meinungen, da sie nur den Film kennt und ich auch die Bücher. - ✨Infos✨ Alternative Folgentitel:

Das Sporttagebuch mit Michael Knöppel - 13. November 2024 E-Mail: sporttagebuch.michael@gmail.com Instagram: @das_sporttagebuch Twitter: @Sporttagebuch_

Harald bedient Manuel. Und greift ihn mit einer meterlangen Pfeffermühle an. Wenig Parmesan, viel Kinderteller Mussolini. Und dann klaut Manuel dem Chef noch einen Super-Gag.

In this episode, we journey through a series of inspiring stories and expert discussions about the power of healing through innovative medical techniques and patient care strategies. Witness a heartwarming reunion that turns into a deep dive into Frequency Specific Microcurrent (FSM), exploring its profound impact on patients with severe pain and chronic conditions. Learn from compelling case studies and expert insights on pain management, mental health, and the role of language in treatment. Discover the transformative potential of epigenetics and mind-body therapies, and how patients can take control of their healing processes. Join us for engaging conversations, practical advice, and real-life examples of how collaboration, adaptability, and continuous learning can lead to breakthroughs in medical practice and patient outcomes. 00:00 Reunited and It Feels So Good 02:16 The Power of Flexibility and Adaptation 03:36 Creative Solutions and Improvisations 04:02 The Legacy of Netter's Medical Illustrations 04:51 A Heartfelt Reunion 05:16 Overseas Adventures and Insights 05:29 The Joy of Continuous Learning 06:19 FSM: Simple Fixes for Complex Problems 06:40 A Case Study: Chronic Pain and Innovative Treatments 21:54 The Importance of Words in Healing 24:38 Dupuytren's Contracture: A Deep Dive 28:50 Connecting the Dots in FSM 29:43 Learning from Patterns and Advice 30:22 The Importance of Collaboration 31:02 Rapid Results and Client Safety 31:23 Challenges in Treating Dupuytren's Contracture 36:36 Understanding Tendinopathy 45:27 Empowering Patients with Knowledge 53:25 Upcoming Symposium and Final Thoughts   Epic Advice: What You Need Shows Up It's crucial to trust that what we need will eventually manifest, albeit in unexpected forms. Herein lies an epic piece of advice shared—embracing this mindset alleviates anxiety for those with type-A personalities, encouraging a survival kit of adaptability in ever-changing environments.   Healing Beyond Boundaries: The Magic of FSM In the core of this discussion lies the heart of Frequency Specific Microcurrent (FSM) therapy. Kim passionately talks about its magic—the swift relief it brings to complex physical ailments that seem eternal and its ability to change lives one patient at a time. Through real case stories, she illustrates how a simple shift in approach can unearth significant changes. FSM offers a reprieve and hope for those suffering chronic pain, teaching practitioners to respect its rapid outcomes and adapt strategies for lifelong benefits.   Diving Into Case Studies: An FSM Journey The symptoms and stories of various patients, including a gripping account of managing Dupuytren's contracture, highlight the power of FSM. Practitioners who faced curse-like chronic ailments saw light through this revolutionary therapy. Highlighting detailed case reports, Kim explains breakthroughs achieved with FSM, signifying its pivotal role in modern medical practices.   These case studies reflect the intertwining of knowledge, skill, and innovation that FSM supports, uncovering connections unseen in conventional treatments. They reiterate the FSM mantra: "think in three dimensions" to implement successful healing journeys.   Words Hold Power: Changing Narratives for Better Healing Kim emphasizes the importance of changing nomenclature in practice, accentuating how the words we use can impact patient mindsets and outcomes. Renaming 'concussion' to a more neutral term like 'Brain Balance' to alleviate anxiety is one such example. Words can invoke different emotions; the right language prepares the body and mind for healing.   Harnessing Internal Power: Mantras and Epigenetics Mantras like "I am safe," "This feels strong," and "Movement feels good" were highlighted as transformative tools fostering emotional safety during treatments. Delving into the realm of epigenetics, the speakers shared insights into how the environment affects genetic expression, showing promising ways to empower patients with autoimmune diseases to change their narratives.   Honoring the Journey At the essence of FSM lies a powerful message—each patient deserves happiness and healing. Healing isn't just freeing one from pain; it's about elevating the entire life experience and understanding that we are all integral parts of a bigger picture with our stories interlinking in the vast tapestry of life. FSM continues to unlock doors to miraculous recovery, not by magic but through steadfast learning, compassionate patience, and creative problem-solving. Each session is a tribute to selfless purveyance among practitioners and the shared mission of changing lives, one patient at a time.

In this episode, Thor R. Halfdanarson, MD, and Jonathan Strosberg, MD, discuss important topics related to gastroenteropancreatic neuroendocrine tumors (GEP-NETs), including:The diagnosis and typical presenting symptoms of GEP-NETsFindings from recent key phase III studies including NETTER-2 and CABINETRecommendations for treatment sequencingNotable clinical pearls regarding GEP-NET therapiesCurrent guidelines for GEP-NET care and monitoringPresenters:Thor R. Halfdanarson, MDConsultant, Division of Medical OncologyProfessor of OncologyAssociate Professor of MedicineMayo Clinic Comprehensive Cancer CenterChair, Hepato-Pancreatico-Biliary Disease GroupRochester, MinnesotaJonathan StrosbergProfessor, GI OncologyChair, Neuroendocrine Tumor DivisionMoffitt Cancer Center and Research InstituteTampa, FloridaLink to full program: https://bit.ly/3Y0JWBa

Hva har den moderne livsstilen med skjermer, blått lys og elektronikk gjort med døgnbiologien vår? Blir vi sykere og tykkere av blått lys og for mye inneklima? Har det blå lyset forringet og forstyrret kroppens døgnklokke? Når er immunsystemet sterkest og når på døgneter det best å trene og spise? Denne indre selvgående klokken heter Suprachiasmticus nucleus og er en superklokke som registrerer all aktivitet fra lys i forhold til jordens rotasjon som er 24 timer. Lever vi ikke i takt med denne klokken/innebygde timeplanenvår kan vi bli syke, deprimerte, overvektige og pådra oss mange alvorlige sykdommer. Trosser du hormonenes naturlige syklus kan det også trigge utmattelse og sykdom.Hvorfor har vi en 24 timers klokken, hva gjør den?hva er den cirkadiske, den infradiske rytmen og den ultradiske rytmen?Hva er zeitgevers og hvilke er de viktigste tegnene?Hva gjør masterklokken Suprachiasmticus nucleus?Når er det best å spise og trene i forhold til klokken vår? hva skjer dersom man ikke gjør dette etter klokken?Når er det best å faste i forhold til vekt og søvn?Hva skjer med insulin og blodsukker når vi spiser for sent?Hvordan kan en optimal spisedag se ut utifra et biorytme perspektiv?Hvordan virker kroppens avfallsprodukt adenosin i forhold til søvn?Hva skjer når vi drikker kaffe? (og kanskje du vil tilsette Ltheanin..)Hvordan fungerer hormonet søvnhormonet melatonin i forhold til superklokken i hjernen?hva skjer når kortisolet vekker kroppen og skyver bort melatoninet?hva gjør kortisolet med sulthormonene?Hva kan vi gjør for å få en fast helsebringende rytme, hvor skal vi starte?Hva er sosialt jetlag og hvordan sliter dette på oss og cellene?Hva tenker Sara om blålysbriller og nærsynthet? Hvorfor er det blå lyset fra solen nyttig?Hva betyr døgnbiologi for ungdommen og hva er differensieringen der?Hva Sara som småbarnsmamma observerer selv når døgnets rytme og søvn blir utfordret?Hvorfor er vi så flinke med rytmen til våre barn, og så glemmer vi det?Når er barnets døgnrytme ferdig utviklet mht hjernen og hormoner?Hvordan forandrer døgnbiologien seg gjennom livet og hva er forskjellen på menn og kvinner?Hvorfor er det smart å få klamydia på morgenkvisten fremfor på kvelden?Når er immunsystemet sterkest?Hvordan spiller kronotypen din inn på trening og mat?Hva betyr det at kreft har en egen døgnrytme, og når virker cellegift best?Når på døgnet virker hjernen best?Kjøp boken "Kroppens rytme" her: https://www.ark.no/forfattere/sara-t-nolandPå instagram finner du Sara her: @saranoelandOslo skin lab: https://www.osloskinlab.noRabattkode: Biohacking60

Rev. Rene Netter - Way-Seeking Mind

After the 2024 Gastrointestinal Cancers Symposium, Jun Gong, MD, and Daneng Li, MD, sat down to discuss the most relevant trial data to have come from the conference. They convened for a live X Space hosted by CancerNetwork®. During the discussion, they covered different trials across the gastrointestinal space, which included those evaluating different disease states from hepatocellular carcinoma (HCC) to colorectal cancer (CRC), and those assessing circulating tumor DNA (ctDNA) dynamics. Gong, a hematologic oncologist focusing on gastrointestinal and genitourinary cancers at Cedars-Sinai Medical Center, and Li, an associate professor in the Department of Medical Oncology and Therapeutics Research at City of Hope, each gave their perspective on the clinical trial data and discussed if they had implemented any of these study treatments into clinical practice.  The studies they covered included:  1.        Phase 3 NETTER-2 Trial (NCT03972488)1: - Investigated lutetium Lu 177 dotatate (Lutathera) plus octreotide vs octreotide alone for advanced gastroenteropancreatic neuroendocrine tumors (GEP-NETs). - Lutetium Lu 177 significantly improved progression-free survival (PFS) and overall response rate (ORR) compared with octreotide alone. - The agent may be considered for patients with high-grade GEP-NETs who desire significant tumor shrinkage. 2.        Phase 3 EMERALD-1 Trial (NCT03778957)2: - Studied transarterial chemoembolization (TACE) plus durvalumab (Imfinzi) with or without bevacizumab (Avastin) for unresectable HCC. - Durvalumab/bevacizumab plus TACE improved PFS compared with placebo plus TACE. - TACE may be preferred over transarterial radioembolization (TARE) due to faster patient recovery. 3.        Phase 3 CheckMate-8HW Trial3: - Evaluated nivolumab (Opdivo) plus ipilimumab (Yervoy) vs chemotherapy for first-line treatment of microsatellite instability-high/mismatch repair deficient metastatic CRC. - Nivolumab/ipilimumab demonstrated superior PFS compared with chemotherapy. - Chemotherapy may no longer be the standard first-line treatment for this patient population. 4.        BESPOKE Study (NCT04264702)4: - Assessed the impact of minimal residual disease (MRD) detected by ctDNA on disease recurrence in patients with stage II and III CRC receiving adjuvant chemotherapy. - MRD positivity was associated with worse disease-free survival (DFS). - ctDNA clearance at 12 weeks indicated improved DFS.  5.        GALAXY Trial5: - ctDNA is a promising biomarker that can be used to predict recurrence in patients with CRC. - Patients with ctDNA-positive disease had a worse DFS than patients with ctDNA-negative disease. - This suggests that ctDNA may be useful for making treatment decisions, but more research is needed before it can be used in clinical practice. 6.        Phase 3 FRESCO-2 Trial (NCT04322539)6: - Fruquintinib (Fruzaqla) improved the quality of life in patients with metastatic CRC when combined with best supportive care and significantly improved quality-adjusted time without symptoms of disease or toxicity compared with placebo and best supportive care. - The study showed positive effects on PFS, response rate, disease control, and duration of response with the fruquintinib combination. - The findings from this trial supported the FDA approval of fruquintinib for metastatic CRC in November 2023.7 References 1.        Singh S, Halperin D, Myrehaug S, et al. [177Lu]Lu-DOTA-TATE in newly diagnosed patients with advanced grade 2 and grade 3, well-differentiated gastroenteropancreatic neuroendocrine tumors: primary analysis of the phase 3 randomized NETTER-2 study. J Clin Oncol. 2024(suppl 3):LBA588. doi:10.1200/JCO.2024.42.3_suppl.LBA588 2.        Lencioni R, Kudo M, Erinjeri J, et al. EMERALD-1: a phase 3, randomized, placebo-controlled study of transarterial chemoembolization combined with durvalumab with or without bevacizumab in participants with unresectable hepatocellular carcinoma eligible for embolization. J Clin Oncol. 2024;42(suppl 3):LBA432. doi.10.1200/JCO.2024.42.3_suppl.LBA432 3.        Andre T, Elez E, Van Cutsem E, et al. Nivolumab (NIVO) plus ipilimumab (IPI) vs chemotherapy (chemo) as first-line (1L) treatment for microsatellite instability-high/mismatch repair-deficient (MSI-H/dMMR) metastatic colorectal cancer (mCRC): First results of the CheckMate 8HW study. J Clin Oncol. 2024;42(suppl_3):LBA768. doi.10.1200/JCO.2024.42.3_suppl.LBA768 4.        Kasi P, Aushev V, Ensor J, et al. Circulating tumor DNA (ctDNA) for informing adjuvant chemotherapy (ACT) in stage II/III colorectal cancer (CRC): interim analysis of BESPOKE CRC study. J Clin Oncol. 2024;42 (suppl _3):9. doi:10.1200/JCO.2024.42.3_suppl.9 5.        Yukami H, Nakamura Y, Mishima S, et al. Circulating tumor DNA (ctDNA) dynamics in patients with colorectal cancer (CRC) with molecular residual disease: Updated analysis from GALAXY study in the CIRCULATE-JAPAN. J Clin Oncol. 2024;42(suppl_3):6. doi:10.1200/JCO.2024.42.3_suppl.6 6.        Stintzing S, Tabernero J, Satoh T, et al. Quality-adjusted time without symptoms of disease or toxicity (Q-TWiST) analysis of fruquintinib + best supportive care (BSC) compared with placebo + BSC in metastatic colorectal cancer (mCRC): results from the FRESCO-2 trial. J Clin Oncol. 2024;42(suppl 3):116. doi:10.1200/JCO.2024.42.3_suppl.116 7.        FDA approves fruquintinib in refractory metastatic colorectal cancer. FDA. News release. November 8, 2023. Accessed February 7, 2024. https://shorturl.at/isJW2

The Capitals end a six-game losing streak by blanking the top team in the East. AP correspondent Dave Ferry reports.

On today's show, Mike Netter discusses breaking US political news. GUEST OVERVIEW: Mike Netter, Vice Chair of Rebuild California and KABC Radio Host is a veteran of distribution, sales and marketing. He is now applying his business expertise to state politics to create a powerful team of volunteers and allied organizations to further the cause of conservatism in the State of California. Mike helped spearhead the effort to recall Gavin Newsom. https://www.rebuildcalifornia.com/ X: @nettermike

In discussion with Dr. Pamela Kunz, covering the Gastroenterology ASCO 2024 meeting highlights from Community Oncology perspective. We covered 3 important practice informing studies from GI ASCO with Dr. Kunz: - CheckMate 8HW: Nivolumab plus ipilimumab vs chemotherapy as first-line (1L) treatment for microsatellite instability-high/mismatch repair-deficient (MSI-H/dMMR) metastatic colorectal cancer - EMERALD-1: A phase 3, randomized, placebo-controlled study of transarterial chemoembolization combined with durvalumab with or without bevacizumab in participants with unresectable hepatocellular carcinoma eligible for embolization - NETTER-2: [177Lu]Lu-DOTA-TATE in newly diagnosed patients with advanced grade 2 and grade 3, well-differentiated gastroenteropancreatic neuroendocrine tumors

On today's show, Mike Netter discusses the problems with elections in California and the US. Later, Jeremy Beck discusses the latest news items of the day. GUEST 1 OVERVIEW: Mike Netter, Vice Chair of Rebuild California and KABC Radio Host, is a veteran of distribution, sales, and marketing. He is now applying his business expertise to state politics to create a powerful team of volunteers and allied organizations to further the cause of conservatism in the State of California. Mike helped spearhead the effort to recall Gavin Newsom. Learn more at https://www.rebuildcalifornia.com. GUEST 2 OVERVIEW: Jeremy Beck is a senior TNT Producer with a background in political consulting, research, and engineering studies.

GUEST OVERVIEW: Mike Netter, Vice Chair of Rebuild California and KABC Radio Host, is a veteran of distribution, sales, and marketing. He has served in senior executive roles at Corporate Express and Staples, both multinational office products firms. He is now applying his business expertise to state politics to create a powerful team of volunteers and allied organizations to further the cause of conservatism in the State of California. Using the power of social media, Mike helped spearhead the effort to recall Gavin Newsom. Mike is also using his speaking skills to spread awareness to many groups throughout the State. He was educated at San Diego State University in Business and Computer Science. Learn more at https://www.rebuildcalifornia.com/ and follow him on Twitter: @nettermike.

On today's show, Craig Rucker discusses U.S. Climate Skeptics descending on the UN Climate Summit in the oil-producing Middle East. Later, Mike Netter discusses California being among the most unaffordable states for energy. GUEST 1 OVERVIEW: Craig Rucker is the president and founder of CFACT.  GUEST 2 OVERVIEW: Mike Netter, Vice Chair of Rebuild California and KABC Radio Host is a veteran of distribution, sales and marketing. He has served in senior executive roles at Corporate Express and Staples, both multinational office products firms. He is now applying his business expertise to state politics to create a powerful team of volunteers and allied organizations to further the cause of conservatism in the State of California. Using the power of social media, Mike helped spearhead the effort to recall Gavin Newsom. Mike is also using his speaking skills to spread awareness to many groups throughout the State. He was educated at San Diego State University in Business and Computer Science. 

My guest for this week's episode is Mike Netter of Rebuild California. Mike is a citizen activist and radio host on KABC 790 AM in Los Angeles. He helped spearhead the effort to recall Gavin Newsom, and he is currently working to spread the word on several issues critical to California's future: energy & forest management; education; law and order; water; self governance. We discussed the failures of Sacramento that downgrade the quality of life for California's citizens, the power-hungry politicians lining up and waiting for Newsom's departure, and what can be done to save our state. Follow Mike on X Visit Rebuild California's website Outraged, with Mike Netter & Friends | KABC-AM California Liberty Project on Instagram California Liberty Project on X --- Send in a voice message: https://podcasters.spotify.com/pod/show/californialibertyproject/message

GUEST OVERVIEW: Mike Netter, Vice Chair of Rebuild California and KABC Radio Host is a veteran of distribution, sales and marketing. He has served in senior executive roles at Corporate Express and Staples, both multinational office products firms. He is now applying his business expertise to state politics to create a powerful team of volunteers and allied organizations to further the cause of conservatism in the State of California. Using the power of social media, Mike helped spearhead the effort to recall Gavin Newsom. Mike is also using his speaking skills to spread awareness to many groups throughout the State. He was educated at San Diego State University in Business and Computer Science. https://www.rebuildcalifornia.com/ X: @nettermike

On today's show, Jan 6er Kim Sorgente will share his story on the Bryan McClain Show. Kim witnessed Rosanne Borland's death and cried as he recalled begging the police to stop. Later, Mike Netter discusses Newsom in Israel and now in China.

GUEST OVERVIEW: Mike Netter, Vice Chair of Rebuild California and KABC Radio Host is a veteran of distribution, sales and marketing. He has served in senior executive roles at Corporate Express and Staples, both multinational office products firms. He is now applying his business expertise to state politics to create a powerful team of volunteers and allied organizations to further the cause of conservatism in the State of California. Using the power of social media, Mike helped spearhead the effort to recall Gavin Newsom. Mike is also using his speaking skills to spread awareness to many groups throughout the State. He was educated at San Diego State University in Business and Computer Science. https://www.rebuildcalifornia.com/ X: @nettermike

Nudging heißt so viel wie „Anstupsen“ oder „Anschubsen“ und ist eine Strategie, die in nahezu jedem Lebensbereich angewandt werden kann, um Menschen dazu zu bringen, sich auf eine gewünschte Art zu verhalten. Wichtig dabei: Es darf kein Zwang dabei sein, man muss sich auch anders entscheiden können. Allerdings soll man möglichst auch nicht zu sehr merken, dass man in eine bestimmte Richtung gestupst – Kritiker sagen: Manipuliert wird. Können wir dank Nudging zu besseren Menschen werden? Schaffen wir damit mehr Bewusstsein, auch im Klima- und Umweltbereich Und was ist besser: Veränderungen durch Anstupsen herbeiführen zu wollen oder Verbote? Susanne Henn diskutiert mit Prof. Gerd Gigerenzer – Psychologe, Prof. Dr. Stefan Piasecki - Sozialwissenschafter; Hochschule der Polizei in Duisburg, Dr. Klaus von Zahn - Leiter des Umweltschutzamtes der Stadt Freiburg

Diesmal geht es um Sparsamkeit, Sanifair, Spielezeitschriften, den großartigen Stay forever Newsletter (https://www.stayforever.de/newsletter-anmeldung/), Baldurs Gate 3, Sammelhefte, Es war einmal das Leben, verrückte Anhalter, die Kardashians, Dopesick und Painkiller und den TÜV. Außerdem gehen wir auf eine kleine Live-Tour in Bielefeld, Essen und Köln 25.08 Bielefeld (Restkarten) 26.08 Köln 28.08 Essen 02.09 Berlin (verlegt) 05.09 Frankfurt (verlegt) Karten gibt es ab sofort bei [Eventim!](https://www.eventim.de/eventseries/bastian-bielendorfer-reinhard-remfort-alliteration-am-arsch-aaa-podcast-3447644/) Du möchtest mehr über unsere Werbepartner erfahren? Hier findest du alle Infos & Rabatte: https://linktr.ee/AlliterationAmArsch

Today, The Two Mikes again spoke with Mike Netter one of the leaders of the “Rebuild California Movement”, (https://www.rebuildcalifornia.com) the group whose efforts helped to force a recall election for Governor Gavin Newsom. That organization now has 60,000 members in California. In his efforts with “Rebuild California”, Mr. Netter said that he found that the biggest party in the state – as I many other states – is called “apathy”. But that seems to be changing, he said, “there's a point when peoples' backs are so far against the walls” that they suddenly begin to see clearly and understand the hell that is approaching them. One of the prime agents in imposing this sudden clarity is the issue of crime.The problem is so bad in California – especially in the “shithole” of San Francisco – that Newsom's government and its allies in the media and elsewhere cannot hide the disaster. Californians are also learning that the taxes they pay for education have been wasted; the state of California is ranked, for example, 49th out of 50 nationally.Mr. Netter had a world of other informative and shocking items, such as the fact that the greater Los Angeles area is governed by a Board of just five supervisors who control an annual budget of $445 billion, which seems surely to guarantee a good deal of corruption. --Mr. Netter now has a Saturday morning radio show on KABC 790 AM in Los Angeles, which is later available as a podcast. SponsorsCARES Act Stimulus (COVID-19) Employee Retention Tax Credits (ERC): https://www.jornscpa.com/snap/?refid=11454757Cambridge Credit: https://www.cambridge-credit.org/twomikes/ EMP Shield: https://www.empshield.com/?coupon=twomikesOur Gold Guy: https://www.ourgoldguy.com www.TwoMikes.usSubscribe to this show on Rumble and Apple Podcasts. For all of our shows and articles, please visit https://freedomfirstnetwork.com Sign up for pickax, the social media platform that protects free speech, is not beholden to Big Tech, has algorithms that amplify your voice and provides monetization opportunities for content creators. https://pickax.com Protect your wealth from the Biden-induced inflation. Buy gold from Our Gold Guy. https://ourgoldguy.com Start your day with a cup of freedom… Freedom First Coffee that is! It's 100% organic, fire-roasted and tastes like FREEDOM. https://freedomfirstcoffee.com Detox your body from heavy metals and toxins from the zeolite detox recommended by Dr Sherri Tenpenny! Click here for $50 off: https://freedomfirstnetwork.thegoodinside.com/pbx-trial-offer-10c2020/ Pre-order Jeff Dornik's book Following the Leader, which explains how the intelligence agencies use cult tactics to brainwash the masses and push propaganda through cult mentality. https://jeffdornik.com/ftl

In this session I'm doing a deep-dive into a topic that's literally shaping our world, and not always in ways we'd like: Cybersecurity in the age of AI. This week, I sat down with Benjamin Netter, tech junkie and founder of Riot, a cybersecurity company looking to protect the most vulnerable. We delved into the nitty-gritty of data breaches and the risk of your personal information - yes, yours - being leaked on the internet. Sound scary? Well, it is. But fear not, we broke down complex issues, like two-step verification and mobile passcodes, in a way that even my non-tech-savvy friends could grasp. We also unpacked what business and learning leaders can do to prepare their employees and ultimately protect their organizations. And if you're thinking, "well, shouldn't the AI companies be sorting this out?" – we touched on that too. Prepare to have your assumptions challenged, my friends. So, get ready to have your perspectives flipped, your curiosity sparked, and yes, maybe even a tiny bit of paranoia induced (all in the name of good, secure fun, of course!) Don't miss this riveting conversation, full of insights you'll be chewing on long after the video ends. Watch, learn, and let's all do our part to stay secure in this digital age! Show Notes: 0:00 - Introductions 4:09 - The Breach The Changed Everything 12:39 - Breaking Down a Hack 19:18 - How Cybersecurity is Changing 28:02 - Protecting New Employees 33:24 - The Impact of AI 45:55 - Mitigating the Risks 56:11 - Are AI Companies Responsible? --- Support this podcast: https://podcasters.spotify.com/pod/show/learningtechtalks/support

90% of cyberattacks start with human error. In this episode, we speak with the founder of Riot, a platform designed to protect your company by preparing your employees to deal with cyberattacks in a modern and engaging way. The number of cyberattacks exploded last year, and everything suggests it will be even worse going forward. Long before AI steals our jobs, it will enable hackers to craft much more sophisticated attacks at scale. These attacks will be far more personalized, far more difficult to discern, and far more devastating. Riot started at Y Combinator in 2020 and is now protecting more than 200,000 employees worldwide.   In this conversation we touch on: -Benjamin's personal experience with the attack on his first company. -The mission of making cyber security accessible to everyone and affordable for small business and non-profits. -How an intelligent tool, 'Albert', makes the experience personable for employees by offering training in small bites based on the user's role and digital habits. -Why offering a first attack excerise for free can really sell a company on just why they need the service. -His experiences at Y Combinator and why having mentors who have already been where you want to go is important. -Insights into raising $15 million in Series A funding.   Benjamin Netter is a cybersecurity expert and the founder and CEO of Riot, a cybersecurity training tool created for employee protection. Benjamin's platform teaches employees about cybersecurity through mock phishing drills and cyber awareness content custom to each user. Last year, Riot protected cyber attacks across 500 companies.   Connect with Benjamin:   Website: https://www.tryriot.com Twitter: https://twitter.com/tryriotdotcom LinkedIn: https://www.linkedin.com/company/tryriot/ Benjamin's Twitter: https://twitter.com/benjaminnetter Benjamin's LinkedIn: https://www.linkedin.com/in/b-netter/   Connect with Allison: LinkedIn: https://www.linkedin.com/in/allisonsummerschicago/ Website: DisruptiveCEONation.com Twitter: @DisruptiveCEO    #futurist #CEO #startup #startupstory #founder #founderstory #business #businesspodcast #podcast Learn more about your ad choices. Visit megaphone.fm/adchoices

Join us for a conversation from fashion, to phishing, dealing with all the Bob's in IT, and much more. My guest Benjamin Netter, the founder and CEO of Riot, gives us his insight into the journey of his business and how he worked with investors for raising capital. #RickJordan #Podcast #AIWe Meet: Benjamin Netter, Founder/CEO of RiotEpisode References: The Founder - https://www.imdb.com/title/tt4276820/Connect:Connect with Rick: https://linktr.ee/mrrickjordanConnect with Benjamin: https://www.tryriot.com/about Universal Rate & Review: https://lovethepodcast.com/allinwithrickjordanSubscribe & Review to ALL IN with Rick Jordan on YouTube: https://www.youtube.com/c/RickJordanALLINAbout Benjamin: Benjamin is the Founder and CEO of Riot, a cybersecurity platform created for employee protection. Benjamin is an expert at getting inside the minds of hackers and through Riot, he protects employees against cyber attacks through mock phishing drills and cyber awareness programs custom to each user. Benjamin would love to discuss his passion for cybersecurity and helping employees and his own personal entrepreneurial journey.

Today, The Two Mikes spoke with remarkable gentlemen named Mike Netter Mr. Netter lives in Los Angeles and he and only a handful of people -- all political novices -- and a $1,000 war chest at the start, but joined together to form an organization called "Rebuild California" which conducted a grassroots campaign -- the largest volunteer-based recall campaign in U.S. history -- that garnered 2.1 million votes to force a recall election against Democrat Governor Gavin Newsom. Although Newsom won the recall election, he and his party were forced to spend $90 million to defeat the recall process engineered by Rebuild California. Mr. Getter said that the organization took advantage of the fact that California is by its constitution a "direct democracy” and citizens can organize to campaign for recalls, referendums, and initiatives. Twenty other states in the Union have the same constitutional opportunities. Mr. Netter also said that he and his partners in the recall campaign learned the following extremely valuable truths about grassroots campaigning. --Stay as far away from "political consultants" and their companies as possible, they are ineffective and horribly expensive. To make the point Mr. Netter pointed out that in California an individual can purchase from the state the voter data for its 22 million voters for $50. --Door-to-door campaigning and the use of email to contact voters is far less expensive and far more effective than using campaign information by mail. Sending two million political flyers by mail costs one million dollars, while sending one million campaign emails costs $10,000. (Rebuild California sent out 36 million emails in the recall campaign.) -- In California the key demographic was not Black, Asian, Hispanic, LBGTQ, etc. --as the media tells their viewers -- but the over-55 Californians who turned out at a 55-percent rate. Mr. Getter noted that there are six million Hispanic voters in California whose turn-out rate is $25%, and that other minorities more or less mirrored that low turn-out rate. SponsorsCARES Act Stimulus (COVID-19) Employee Retention Tax Credits (ERC): https://www.jornscpa.com/snap/?refid=11454757Cambridge Credit: https://www.cambridge-credit.org/twomikes/ EMP Shield: https://www.empshield.com/?coupon=twomikesOur Gold Guy: https://www.ourgoldguy.com www.TwoMikes.us

No one would have suspected that Philip Markoff, a med student engaged to a beautiful woman, had a secret life. There was a dark side hiding underneath this All-American man, that included BDSM and murder!Join us on Facebook and IG: @HARDCORETRUECRIMEWeb: www.crimesandconsequences.com-------->Get ad-free early releases of each episode, plus over 170 exclusive Members Only episodes by going to Patreon.com/tntcrimes or joining our Apple Channel on the Apple Podcast App.Sources:Boston Police Arrest Booking Form: Markoff, Phillip H. April 20th, 2009. http://i.cdn.turner.com/cnn/2009/images/04/21/documents.pdfClarridge, Emerson. “‘A Bright Boy': New Yorkers remember accused ‘Craigslist Killer' as someone to be proud of.” The Patriot Ledger, April 23rd, 2009. https://www.patriotledger.com/story/news/courts/2009/04/23/bright-boy-new-yorkers/40301903007/Cramer, Maria, and LaRosa, Paul. Seven Days of Rage: The Deadly Crime Spree of the Craigslist Killer. United Kingdom, Pocket Books, 2009.Ford, Beverly and Yaniv, Oren. “New lurid details in case of accused Craigslist killer Phillip Markoff.” New York Daily News, June 22nd, 2009. https://www.nydailynews.com/news/crime/new-lurid-details-case-accused-craigslist-killer-phillip-markoff-article-1.375967Helling, Steve. “‘Murder Made Me Famous': ‘Craigslist Killer' Prosecutor Says ‘Evidence Was Overwhelming'. People.com, April 7th, 2017. https://people.com/crime/murder-made-me-famous-craigslist-killer-prosecutor-says-evidence-was-overwhelming/Jahnke, Art. “Med School Student Charged with Murder.” BU Today, April 21st, 2009. https://www.bu.edu/articles/2009/med-school-student-charged-with-murder/Kickham, William D. “Accused “Craigslist Killer”: Should Charge Be Murder, or Something Else?” Boston Criminal Attorney Blog, May 2nd, 2009. https://www.bostoncriminalattorneyblog.com/accused_craigslist_killer_shou/McPhee, Michelle. “‘Craigslist Killer' Phillip Markoff Died Amid His Fiancee's Photos.” ABC News, August 16th, 2010. https://abcnews.go.com/US/TheLaw/craigslist-killer-philip-markoff-spread-photos-fiance-died/story?id=11419551 Murphy, Shelly. “Markoff victim's kin hits gun sale.” The Boston Globe, April 3rd, 2011. http://archive.boston.com/news/local/massachusetts/articles/2011/04/03/markoff_victims_kin_blames_nh_gun_sale/Netter, Sarah; Friedman, Emily; McPhee, Michele. “Accused ‘Craigslist Killer' Won't See Former Fiancee for ‘Long Period of Time.” ABC News, June 22nd, 2009. https://abcnews.go.com/US/story?id=7904950No Author. “Felony Murder.” Justia.com, 2022. https://www.justia.com/criminal/offenses/homicide/felony-murder/

Shanovia (NoNo) landed in Champaign after being taken out of Chicago with the intention of a happier upbringing. She left behind sadness, poverty and ailing or deceased caregivers.  With little food and living conditions unfit to thrive in, Shanovia and her sisters moved to Champaign to face a new set of challenges.  Listen to why NoNo didn't let her environment define her. Why her inner light would shine on the path that would lead her to a future of service for others, further education and the desire to be a mother her daughter would look up to. NoNo credits many people who gave her a shoulder to cry on, a voice to express herself with, an ear to listen to and a warm, safe home to sleep in. Abby Hobbs, longtime Champaign resident, is one of these people. Abby is a well-known philanthropist and self-appointed second mother to Shanovia. Abby saw NoNo's potential and knew she was destined to take advantage of any opportunity given to her. With all of the cards stacked against her, Shanovia heeded everyone's advice, humbled herself and listened to others. She found a way to become the best version of herself despite the adversity she faced.I'd like to thank this episode's sponsor, Checkered Moon. There is no better place for a gift for someone else or a treat for yourself. Right now the store is dripping in all the things to deck your halls! Make sure to follow them on Instagram and Facebook! Order from their abbreviated selection on their website checkeredmoon.com. They offer gift wrapping and free, local delivery! Holiday shopping has never been more filled with cheer! Thank you so much for listening! However your podcast host of choice allows, please positively: rate, review, comment and give all the stars! Don't forget to follow, subscribe, share and ring that notification bell so you know when the next episode drops! Also, search and follow hyperlocalscu on all social media. If I forgot anything or you need me, visit my website at HyperLocalsCU.com. Byee.

A tous ceux qui utilisent leur date de naissance comme mot de passe (ou qui l'ont fait un jour), cet épisode est fait pour vous. Dans cet échange, Benjamin Netter explique pourquoi la cybersécurité est une question d'éducation. Cofondateur et ancien CTO de October, une étoile de la fintech française, il se rend compte que le problème se situe entre la chaise et le clavier : chez les utilisateurs de systèmes informatiques, donc tout salarié d'une entreprise aujourd'hui. Tombé dans le web étant petit, il raconte sa découverte du hacking à 12 ans et les enseignements qu'il en a tirés. Car en cybersécurité, l'erreur humaine peut être fatale à la sécurité d'un système. ll part de ce constat pour créer Riot, un outil SAAS pour former les salariés aux pratiques de cybersécurité, qu'il code sur son temps libre avant de décrocher une invitation à l'illustre Y-Combinator pour le concrétiser. A 33 ans, Benjamin a su alterner le développement informatique et le costume de chef d'entreprise. Dans cette conversation, il met des mots sur les aspects techniques et humains de l'univers fintech. Voici ce que l'on apprend entre autres lors de cette conversation : 20% des salariés se feront prendre dans les mailles du filet des hackers. #phishing Entre 5 et 8 Millions USD, c'est le prix d'une faille de cybersécurité trouvée chez un GAFAM sur le marché noir. Une demi-seconde suffit à un hacker pour retrouver votre mot de passe s'il a fuité. Qu'un mot de passe fort ne doit surtout pas être logique. Que la vérité sort de la bouche des… utilisateurs. Vous vous demandez encore si ce sujet vous concerne ? La cybersécurité est l'affaire de tous ! Très bonne écoute et n'oubliez pas de changer vos mots de passe ! TIMELINE : 00:004:35 - Présentation 00:34:18 - Le hacking 01:09:00 - Y-Combinator 01:39:36 - L'équipe Riot 01:59:06 - Demo Day 02:14:12 - Investisseur On a cité avec Benjamin plusieurs anciens épisodes de GDIY : #COVID-19 9 - Olivier Goy - October #62 Olivier GOY - October #142 Emmanuel Schalit - Dashlane #214 Mathilde Collin - Front #243 Eric Larchevêque - Ledger #257 Ian Rogers - Ledger #266 Frédéric Plais - Platform.sh #277 Nicolas d'Audiffret - Ankorstore #278 Alexia Laroche-Joubert Benjamin vous recommande de lire : Magellan, Stefan Zweig Avec Benjamin, on a parlé de : Have I been Pawned (site pour vérifier si son mail a fuité) Le guide interne de Benjamin Netter sur le recrutement Matthieu Laulan - Club Bootstrap Cool Paradise Open AI - GPT-3 Nicolas Dessaigne - Algolia "Hard Things" de Ben Horowitz La musique du générique vous plaît ? C'est à Morgan Prudhomme que je la dois ! Contactez-le sur : https://studio-module.com. Vous souhaitez sponsoriser Génération Do It Yourself ou nous proposer un partenariat ? Contactez mon label Orso Media via ce formulaire. Une pensée particulière pour Olivier Goy qu'on adore ! Vous pouvez envoyer un message à Benjamin sur Twitter, Instagram et Linkedin.

Pour découvrir l'épisode en entier tapez "#286 - Benjamin Netter - Riot - Pourquoi la cybersécurité doit être l'affaire de tous" sur votre plateforme d'écoute.

In this episode, we will explore the famous 20th century medical illustrator Frank Netter and his magnum opus, the Atlas of Human Anatomy. While this work is his most famous, many people do not realize that Frank Netter was also a doctor, and (briefly) practiced as a surgeon, before spending the majority of his career as a commercial artist. Have a listen to find out more!